- Healthcare
- Social
- Retail
- Main
You are not logged in!
Do you want to login? It's free!
Who do you implu? Create a Free Account!
1875 EYE STREET, NW
SUITE 400
WASHINGTON DC 20006
USA
On behalf of: TEVA PHARMACEUTICALS USA, INC. (reported on 2009-09-30)
Received: $50000
Agency: U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
Filed under: Copyright / Patent / Trademark, see top firms.
S. 515 - A BILL TO AMEND TITLE 35, UNITED STATES CODE, TO PROVIDE FOR PATENT REFORM.
S. 610 - A BILL TO AMEND TITLE 35, UNITED STATES CODE, TO PROVIDE FOR PATENT REFORM.
H.R. 1260 - TO AMEND TITLE 35, UNITED STATES CODE, TO PROVIDE FOR PATENT REFORM.
Lobbyist(s): GINGER LOPER
Agency: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
Filed under: Health Issues, see top firms.
H.R. 1427 - TO AMEND THE PUBLIC HEALTH SERVICE ACT TO PROVIDE FOR THE LICENSING OF BIOSIMILAR AND BIOGENERIC BIOLOGICAL PRODUCTS, AND FOR OTHER PURPOSES.
S. 726 - A BILL TO AMEND THE PUBLIC HEALTH SERVICE ACT TO PROVIDE FOR THE LICENSING OF BIOSIMILAR AND BIOGENERIC BIOLOGICAL PRODUCTS, AND FOR OTHER PURPOSES.
H.R. 1548 - TO AMEND THE PUBLIC HEALTH SERVICE ACT TO ESTABLISH A PATHWAY FOR THE LICENSURE OF BIOSIMILAR BIOLOGICAL PRODUCTS, AND FOR OTHER PURPOSES.
S. 1213 - A BILL TO AMEND TITLE XI OF THE SOCIAL SECURITY ACT TO PROVIDE FOR THE CONDUCT OF COMPARATIVE EFFECTIVENESS RESEARCH AND TO AMEND THE INTERNAL REVENUE CODE OF 1986 TO ESTABLISH A PATIENT-CENTERED OUTCOMES RESEARCH TRUST FUND, AND FOR OTHER PURPOSES.
S. 1259 - A BILL TO PROTECT ALL PATIENTS BY PROHIBITING THE USE OF DATA OBTAINED FROM COMPARATIVE EFFECTIVENESS RESEARCH TO DENY COVERAGE OF ITEMS OR SERVICES UNDER FEDERAL HEALTH CARE PROGRAMS AND TO ENSURE THAT COMPARATIVE EFFECTIVENESS RESEARCH ACCOUNTS FOR ADVANCEMENTS IN PERSONALIZED MEDICINE AND DIFFERENCES IN PATIENT TREATMENT RESPONSE.
S. 1679 - AN ORIGINAL BILL TO MAKE QUALITY, AFFORDABLE HEALTH CARE AVAILABLE TO ALL AMERICANS, REDUCE COSTS, IMPROVE HEALTH CARE QUALITY, ENHANCE DISEASE PREVENTION, AND STRENGTHEN THE HEALTH CARE WORKFORCE.
H.R. 3200 - TO PROVIDE AFFORDABLE, QUALITY HEALTH CARE FOR ALL AMERICANS AND REDUCE THE GROWTH IN HEALTH CARE SPENDING, AND FOR OTHER PURPOSES.
Lobbyist(s): GINGER LOPER
Agency: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
Filed under: Labor Issues / Antitrust / Workplace, see top firms.
H.R. 1706 - TO PROHIBIT BRAND NAME DRUG COMPANIES FROM COMPENSATING GENERIC DRUG COMPANIES TO DELAY THE ENTRY OF A GENERIC DRUG INTO THE MARKET, AND FOR OTHER PURPOSES.
S. 369 - A BILL TO PROHIBIT BRAND NAME DRUG COMPANIES FROM COMPENSATING GENERIC DRUG COMPANIES TO DELAY THE ENTRY OF A GENERIC DRUG INTO THE MARKET.
Lobbyist(s): GINGER LOPER